Aardvark Therapeutics, Inc.

AARDReported to SECin USCIK 0001774857Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 6
Form 4 lines at Aardvark Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Sun NelsonSee RemarksOpen-market sell$321,17962,000 sharesSep 11, 2026Sun NelsonSee Remarks$321,179Sell · Sep 11Open-market sell62,000Sep 11, 2026
Sun NelsonSee RemarksOpen-market sell$73,77914,754 sharesSep 11, 2026Sun NelsonSee Remarks$73,779Sell · Sep 11Open-market sell14,754Sep 11, 2026
Chi Jeffrey—Awardnothing paid44,964 sharesAug 21, 2026Chi Jeffreynothing paidAward · Aug 21Award44,964Aug 21, 2026
Graf Susan E—Awardnothing paid44,964 sharesAug 21, 2026Graf Susan Enothing paidAward · Aug 21Award44,964Aug 21, 2026
Baynes Roy D.—Awardnothing paid44,964 sharesAug 21, 2026Baynes Roy D.nothing paidAward · Aug 21Award44,964Aug 21, 2026